Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Active, not recruiting · NCT05715931 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | gastric adenocarcinoma | Active, not recruiting | Phase 2 | 2026-09-09 | NCT05715931 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yu jiren | 4 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huzhou Central Hospital | Huzhou | China | 3 |
| Lishui Central Hospital | Lishui | China | 15 |
| Ningbo First Hospital | Ningbo | China | 11 |
| Ningbo Medical Center LiHuiLi Hospital | Ningbo | China | 6 |
| Ningbo Second Hospital | Ningbo | China | 3 |
| Taizhou Hospital | Taizhou | China | 4 |
| The First Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou | China | 12 |
| The Second Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou | China | 4 |